Insider Shareholders with Direct Ownership of Oyster Point Pharma, Inc. (OYST)
This section provides a comprehensive overview of the insiders with direct ownership of Oyster Point Pharma, Inc. (OYST). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Oyster Point Pharma, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Versant Venture Capital Vi, L.P.
> 10% Shareholder |
0 | 2,561,888 | 2,236,888 $0 | 2 |
Feb 17, 2021
Reduced 12.69%
|
|
Kleiner Perkins Caufield & Byers Xiv, Llc
> 10% Shareholder |
45,529 | 0 | 367,987 $0 | 1 |
Nov 04, 2019
Added 11.01%
|
|
Jeffrey Nau
President and CEO |
152,598 | 157,537 | 151,381 $0 | 9 |
Dec 01, 2022
Reduced 3.94%
|
|
John Snisarenko
Chief Commercial Officer |
23,322 | 0 | 30,322 $0 | 2 |
Jan 09, 2022
Added 28.52%
|
|
Clare Ozawa
Director |
8,037 | 14,637 | 14,637 $0 | 8 |
Jun 06, 2022
Added 19.62%
|
|
William J Phd Link
Director |
3,466 | 0 | 10,066 $0 | 1 |
Jun 07, 2021
Added 25.61%
|
|
Ali Behbahani
Director |
7,039 | 13,639 | 0 $0 | 3 |
Jan 03, 2023
Reduced 100.0%
|
|
Daniel Lochner
Chief Financial Officer |
63,421 | 80,721 | 0 $0 | 9 |
Jan 03, 2023
Reduced 100.0%
|
|
Aimee S Weisner
Director |
7,039 | 36,764 | 0 $0 | 3 |
Jan 03, 2023
Reduced 100.0%
|
|
Michael G Atieh
Director |
26,734 | 26,734 | 0 $0 | 4 |
Jan 03, 2023
Reduced 100.0%
|
|
George Christopher Eliades
Director |
28,624 | 28,624 | 0 $0 | 4 |
Jan 03, 2023
Reduced 100.0%
|
|
Benjamin Tsai
Director |
7,039 | 13,639 | 0 $0 | 3 |
Jan 03, 2023
Reduced 100.0%
|
|
Mark Anthony Murray
Director |
7,039 | 122,086 | 0 $0 | 3 |
Jan 03, 2023
Reduced 100.0%
|
|
Donald J Santel
Director |
13,687 | 13,687 | 0 $0 | 3 |
Jan 03, 2023
Reduced 100.0%
|
|
New Enterprise Associates 14, L.P.
> 10% Shareholder |
0 | 5,925,287 | 0 $0 | 1 |
Jan 03, 2023
Reduced 100.0%
|